Star Combo Pharma Ltd
Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its pro… Read more
Star Combo Pharma Ltd - Asset Resilience Ratio
Star Combo Pharma Ltd (S66) has an Asset Resilience Ratio of 67.35% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how Star Combo Pharma Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Star Combo Pharma Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$18.11 Million | 37.38% |
| Short-term Investments | AU$14.52 Million | 29.97% |
| Total Liquid Assets | AU$32.63 Million | 67.35% |
Asset Resilience Insights
- Very High Liquidity: Star Combo Pharma Ltd maintains exceptional liquid asset reserves at 67.35% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Star Combo Pharma Ltd Industry Peers by Asset Resilience Ratio
Compare Star Combo Pharma Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Lonkey Industrial Co Ltd Guangzhou
SHE:000523 |
Household & Personal Products | 0.13% |
|
Taiyen Biotech Co Ltd
TW:1737 |
Household & Personal Products | 4.80% |
|
Tianjin Yiyi Hygiene Products Co Ltd
SHE:001206 |
Household & Personal Products | 24.73% |
|
Hunan Resun Co Ltd
SHE:001218 |
Household & Personal Products | 6.95% |
|
Dencare (Chongqing) Oral Care Co. Ltd. A
SHE:001328 |
Household & Personal Products | 42.83% |
|
Qingdao Kingking Applied Chemistry Co Ltd
SHE:002094 |
Household & Personal Products | 0.00% |
|
C&S Paper Co Ltd
SHE:002511 |
Household & Personal Products | 8.72% |
|
Anhui Deli Household Glass Co Ltd
SHE:002571 |
Household & Personal Products | 0.11% |
Annual Asset Resilience Ratio for Star Combo Pharma Ltd (2019–2025)
The table below shows the annual Asset Resilience Ratio data for Star Combo Pharma Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 29.97% | AU$14.52 Million | AU$48.45 Million | +17.84pp |
| 2024-06-30 | 12.13% | AU$5.20 Million | AU$42.82 Million | -18.65pp |
| 2023-06-30 | 30.79% | AU$13.00 Million | AU$42.23 Million | +3.16pp |
| 2022-06-30 | 27.62% | AU$12.00 Million | AU$43.44 Million | -23.44pp |
| 2021-06-30 | 51.06% | AU$22.12 Million | AU$43.32 Million | +14.51pp |
| 2020-06-30 | 36.55% | AU$20.00 Million | AU$54.72 Million | +32.91pp |
| 2019-06-30 | 3.64% | AU$1.00 Million | AU$27.51 Million | -- |